Context Therapeutics Inc (CNTX)
2.00
-0.01
(-0.50%)
USD |
NASDAQ |
Jun 28, 16:00
2.00
0.00 (0.00%)
After-Hours: 20:00
Context Therapeutics Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.50M |
| June 30, 2022 | -0.0018M |
| March 31, 2022 | -0.035M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.25M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.50M
Minimum
Sep 2022
--
Maximum
Jun 2020
-0.0562M
Average
--
Median
Jun 2020
Cash from Investing (Quarterly) Benchmarks
| Emergent BioSolutions Inc | -10.80M |
| AbbVie Inc | -9.588B |
| Revance Therapeutics Inc | -31.71M |
| Design Therapeutics Inc | 20.62M |
| NovaBay Pharmaceuticals Inc | 1.068M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.361M |
| Free Cash Flow | -19.68M |
| Free Cash Flow Per Share (Quarterly) | -0.2731 |
| Free Cash Flow Yield | -61.63% |